What type of study is this?

December 8, 2025BloodOpen Access

A decade of progress: A comparative analysis of real-world survival in chronic lymphocytic leukemia across therapeutic eras

View Full Paper

Ask AI

Bookmark

Authors

DEDavid J. ElliottNewcastle University AAAmina AsadJohn Sealy Hospital ETEkrem TurkMoffitt Cancer Center

Discussion

Member takes

Implication

Retrospective cohort analysis shows improved mortality with targeted therapy in chronic lymphocytic leukemia, suggesting a shift in treatment standards.

Key Points

Overall survival significantly improved for CLL diagnosed post-2015 compared to pre-2015.
Patients receiving targeted therapy had lower all-cause mortality and relapse rates than those on chemoimmunotherapy.
Propensity score-matched analysis validated survival benefits and treatment effectiveness across therapies.
Results may guide future treatment protocols, favoring the use of novel targeted agents in managing CLL.

Cite This Study

Elliott et al. (2025) studied this question.

synapsesocial.com/papers/69362f714fa91c937236e1b9 https://doi.org/10.1182/blood-2025-3911

View Full Paper

Ask AI

Bookmark

Implication

Retrospective cohort analysis shows improved mortality with targeted therapy in chronic lymphocytic leukemia, suggesting a shift in treatment standards.

A decade of progress: A comparative analysis of real-world survival in chronic lymphocytic leukemia across therapeutic eras

Discussion

Member takes

Implication

Key Points

Cite This Study

A decade of progress: A comparative analysis of real-world survival in chronic lymphocytic leukemia across therapeutic eras

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider